Melanoma trials in Uganda

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Not yet taking people in Uganda
  Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

  Where

  Kampala

  Age

  18 years and over

  People

  50

  Run by

  Fred Hutchinson Cancer Center

  See details and how to joinNCT07576725